Trials / Unknown
UnknownNCT02802267
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Hybrigenics Corporation · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the effect of the addition of inecalcitol to decitabine treatment on overall survival in previously untreated AML patients aged 65 years or more who are randomly assigned to receive decitabine with or without inecalcitol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inecalcitol | vitamin D receptor agonist |
| DRUG | Placebo Oral Tablet | placebo |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-01
- First posted
- 2016-06-16
- Last updated
- 2017-07-02
Locations
8 sites across 2 countries: United States, France
Source: ClinicalTrials.gov record NCT02802267. Inclusion in this directory is not an endorsement.